These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 37321178)

  • 1. Correcting dysbiosis in the lungs of COPD, one pathogen at a time.
    Wong KK; Segal LN
    Cell Host Microbe; 2023 Jun; 31(6):925-927. PubMed ID: 37321178
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Airway dysbiosis accelerates lung function decline in chronic obstructive pulmonary disease.
    Liang W; Yang Y; Gong S; Wei M; Ma Y; Feng R; Gao J; Liu X; Tu F; Ma W; Yi X; Liang Z; Wang F; Wang L; Chen D; Shu W; Miller BE; Tal-Singer R; Donaldson GC; Wedzicha JA; Singh D; Wilkinson TMA; Brightling CE; Chen R; Zhong N; Wang Z
    Cell Host Microbe; 2023 Jun; 31(6):1054-1070.e9. PubMed ID: 37207649
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Different expression ratio of S100A8/A9 and S100A12 in acute and chronic lung diseases.
    Lorenz E; Muhlebach MS; Tessier PA; Alexis NE; Duncan Hite R; Seeds MC; Peden DB; Meredith W
    Respir Med; 2008 Apr; 102(4):567-73. PubMed ID: 18164192
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sputum microbiome temporal variability and dysbiosis in chronic obstructive pulmonary disease exacerbations: an analysis of the COPDMAP study.
    Wang Z; Singh R; Miller BE; Tal-Singer R; Van Horn S; Tomsho L; Mackay A; Allinson JP; Webb AJ; Brookes AJ; George LM; Barker B; Kolsum U; Donnelly LE; Belchamber K; Barnes PJ; Singh D; Brightling CE; Donaldson GC; Wedzicha JA; Brown JR;
    Thorax; 2018 Apr; 73(4):331-338. PubMed ID: 29269441
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High levels of S100A8/A9 proteins aggravate ventilator-induced lung injury via TLR4 signaling.
    Kuipers MT; Vogl T; Aslami H; Jongsma G; van den Berg E; Vlaar AP; Roelofs JJ; Juffermans NP; Schultz MJ; van der Poll T; Roth J; Wieland CW
    PLoS One; 2013; 8(7):e68694. PubMed ID: 23874727
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The heterodimer S100A8/A9 is a potent therapeutic target for idiopathic pulmonary fibrosis.
    Araki K; Kinoshita R; Tomonobu N; Gohara Y; Tomida S; Takahashi Y; Senoo S; Taniguchi A; Itano J; Yamamoto KI; Murata H; Suzawa K; Shien K; Yamamoto H; Okazaki M; Sugimoto S; Ichimura K; Nishibori M; Miyahara N; Toyooka S; Sakaguchi M
    J Mol Med (Berl); 2021 Jan; 99(1):131-145. PubMed ID: 33169236
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characteristics of the sputum microbiome in COPD exacerbations and correlations between clinical indices.
    Su L; Qiao Y; Luo J; Huang R; Li Z; Zhang H; Zhao H; Wang J; Xiao Y
    J Transl Med; 2022 Feb; 20(1):76. PubMed ID: 35123490
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The antimicrobial peptide S100A8/A9 produced by airway epithelium functions as a potent and direct regulator of macrophage phenotype and function.
    Skronska-Wasek W; Durlanik S; Le HQ; Schroeder V; Kitt K; Garnett JP; Pflanz S
    Eur Respir J; 2022 Apr; 59(4):. PubMed ID: 34561292
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Links Between Inflammatory Bowel Disease and Chronic Obstructive Pulmonary Disease.
    Raftery AL; Tsantikos E; Harris NL; Hibbs ML
    Front Immunol; 2020; 11():2144. PubMed ID: 33042125
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deficiency of S100A8/A9 attenuates pulmonary microvascular leakage in septic mice.
    Yu J; Zhao B; Pi Q; Zhou G; Cheng Z; Qu C; Wang X; Kong L; Luo S; Du D; Guo Y
    Respir Res; 2023 Nov; 24(1):288. PubMed ID: 37978525
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IL-17 stimulates neutrophils to release S100A8/A9 to promote lung epithelial cell apoptosis in Mycoplasma pneumoniae-induced pneumonia in children.
    Bai S; Wang W; Ye L; Fang L; Dong T; Zhang R; Wang X; Gao H; Shen B; Ding S
    Biomed Pharmacother; 2021 Nov; 143():112184. PubMed ID: 34562768
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sputum Microbiome Is Associated with 1-Year Mortality after Chronic Obstructive Pulmonary Disease Hospitalizations.
    Leitao Filho FS; Alotaibi NM; Ngan D; Tam S; Yang J; Hollander Z; Chen V; FitzGerald JM; Nislow C; Leung JM; Man SFP; Sin DD
    Am J Respir Crit Care Med; 2019 May; 199(10):1205-1213. PubMed ID: 30376356
    [No Abstract]   [Full Text] [Related]  

  • 13. Airway host-microbiome interactions in chronic obstructive pulmonary disease.
    Wang Z; Maschera B; Lea S; Kolsum U; Michalovich D; Van Horn S; Traini C; Brown JR; Hessel EM; Singh D
    Respir Res; 2019 Jun; 20(1):113. PubMed ID: 31170986
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of pulmonary microorganisms in the development of chronic obstructive pulmonary disease.
    Liu J; Ran Z; Wang F; Xin C; Xiong B; Song Z
    Crit Rev Microbiol; 2021 Feb; 47(1):1-12. PubMed ID: 33040638
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gut Microbiome as a Possible Cause of Occurrence and Therapeutic Target in Chronic Obstructive Pulmonary Disease.
    Lim EY; Song EJ; Shin HS
    J Microbiol Biotechnol; 2023 Sep; 33(9):1111-1118. PubMed ID: 37164760
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multi-omics analyses of airway host-microbe interactions in chronic obstructive pulmonary disease identify potential therapeutic interventions.
    Yan Z; Chen B; Yang Y; Yi X; Wei M; Ecklu-Mensah G; Buschmann MM; Liu H; Gao J; Liang W; Liu X; Yang J; Ma W; Liang Z; Wang F; Chen D; Wang L; Shi W; Stampfli MR; Li P; Gong S; Chen X; Shu W; El-Omar EM; Gilbert JA; Blaser MJ; Zhou H; Chen R; Wang Z
    Nat Microbiol; 2022 Sep; 7(9):1361-1375. PubMed ID: 35995842
    [TBL] [Abstract][Full Text] [Related]  

  • 17. S100A8 and S100A9 Are Important for Postnatal Development of Gut Microbiota and Immune System in Mice and Infants.
    Willers M; Ulas T; Völlger L; Vogl T; Heinemann AS; Pirr S; Pagel J; Fehlhaber B; Halle O; Schöning J; Schreek S; Löber U; Essex M; Hombach P; Graspeuntner S; Basic M; Bleich A; Cloppenborg-Schmidt K; Künzel S; Jonigk D; Rupp J; Hansen G; Förster R; Baines JF; Härtel C; Schultze JL; Forslund SK; Roth J; Viemann D
    Gastroenterology; 2020 Dec; 159(6):2130-2145.e5. PubMed ID: 32805279
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The sputum microbiome is distinct between COPD and health, independent of smoking history.
    Haldar K; George L; Wang Z; Mistry V; Ramsheh MY; Free RC; John C; Reeve NF; Miller BE; Tal-Singer R; Webb AJ; Brookes AJ; Tobin MD; Singh D; Donaldson GC; Wedzicha JA; Brown JR; Barer MR; Brightling CE
    Respir Res; 2020 Jul; 21(1):183. PubMed ID: 32664956
    [TBL] [Abstract][Full Text] [Related]  

  • 19. S100A8/A9 in COVID-19 pathogenesis: Impact on clinical outcomes.
    Mellett L; Khader SA
    Cytokine Growth Factor Rev; 2022 Feb; 63():90-97. PubMed ID: 34728150
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of exacerbation phenotype with the sputum microbiome in chronic obstructive pulmonary disease patients during the clinically stable state.
    Yang CY; Li SW; Chin CY; Hsu CW; Lee CC; Yeh YM; Wu KA
    J Transl Med; 2021 Mar; 19(1):121. PubMed ID: 33757530
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.